Silver Spring, Maryland—(ENEWSPF)—April 12, 2018
By: Angela Stark
The U.S. Food and Drug Administration (FDA) permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.
Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissue in the back…
